Furthermore, enzymes involved in the metabolism of pyridoxate and PLP were found to be differentially expressed in TD patients: ALPL—that catalyzes the dephosphorylation of PLP to pyridoxal (the transportable form of vitamin B6)—was upregulated in the postmortem striatum of TD patients [64], while PDXK—that catalyzes the conversion of vitamin B6 precursors to their phosphorylated counterparts, including PLP—and PHOSPHO2—that dephosphorylates PLP—were downregulated in the blood of children with TD [66]. This evidence concerns the gene PDXK and thanatophoric dysplasia.